Literature DB >> 35546470

Role of Vitamin D in COVID-19: Correspondence.

Pathum Sookaromdee1, Viroj Wiwanitkit2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35546470      PMCID: PMC9249158          DOI: 10.4103/ijp.ijp_897_21

Source DB:  PubMed          Journal:  Indian J Pharmacol        ISSN: 0253-7613            Impact factor:   2.833


× No keyword cloud information.
Sir, We would like to share ideas on “Evidences suggesting a possible role of Vitamin D in COVID 19: The missing link.”[1] Singh et al. concluded that “Using Vitamin D as prophylaxis and/or chemotherapeutic treatment … of Vitamin D affecting many people worldwide.”[1] We agree that Vitamin D might play a role in the management of COVID-19. Trials might be useful. Considering trial, some important concerns are hereby discussed. First, it should assess the impact of genetic polymorphism. Vitamin D-binding protein polymorphism might be associated with outcome of Vitamin D supplementation in the COVID-19 treatment.[2] Additionally, if a trial will be performed, a background Vitamin D data of subjects should be assessed. The effect of Vitamin D in COVID-19 might also be associated with some other modifiers. Sunlight exposure and estrogen interaction should be discussed. Estradiol is also proposed for its usefulness in managing COVID-19.[3] There might be an interesting co-advantage of both Vitamin D and estradiol in the management of COVID-19.

Financial support and sponsorship

Nil.

Conflicts of interest

The authors ask for waiving for any charge for this correspondence.
  3 in total

1.  Therapeutic application of estrogen for COVID-19: Attenuation of SARS-CoV-2 spike protein and IL-6 stimulated, ACE2-dependent NOX2 activation, ROS production and MCP-1 upregulation in endothelial cells.

Authors:  Ji Youn Youn; Yixuan Zhang; Yusi Wu; Maxime Cannesson; Hua Cai
Journal:  Redox Biol       Date:  2021-08-17       Impact factor: 11.799

Review 2.  Evidences suggesting a possible role of Vitamin D in COVID 19: The missing link.

Authors:  Shruti Singh; C M Singh; Alok Ranjan; Sanjeev Kumar; Dheeraj Kumar Singh
Journal:  Indian J Pharmacol       Date:  2021 Sep-Oct       Impact factor: 1.200

3.  The potential significance of vitamin D binding protein polymorphism in COVID-19.

Authors:  Marijn M Speeckaert; Joris R Delanghe
Journal:  Int J Infect Dis       Date:  2021-06-24       Impact factor: 3.623

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.